Core Scientific, Inc.
CORZ
$16.42
-$0.55-3.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 58.87% | 46.04% | |||
| Total Other Revenue | -26.59% | -7.99% | |||
| Total Revenue | -1.65% | 3.15% | |||
| Cost of Revenue | -43.62% | 4.88% | |||
| Gross Profit | 828.04% | -22.29% | |||
| SG&A Expenses | -41.77% | 12.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 662.83% | 63.23% | |||
| Total Operating Expenses | 9.44% | 29.12% | |||
| Operating Income | -27.81% | -121.47% | |||
| Income Before Tax | 246.21% | 84.36% | |||
| Income Tax Expenses | -24.00% | -20.89% | |||
| Earnings from Continuing Operations | 246.02% | 84.34% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 246.02% | 84.34% | |||
| EBIT | -27.81% | -121.47% | |||
| EBITDA | -48.55% | -871.33% | |||
| EPS Basic | 227.54% | 45.11% | |||
| Normalized Basic EPS | 316.03% | 86.80% | |||
| EPS Diluted | 187.84% | 45.36% | |||
| Normalized Diluted EPS | 248.59% | 86.80% | |||
| Average Basic Shares Outstanding | 0.33% | 0.18% | |||
| Average Diluted Shares Outstanding | 45.83% | 0.18% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||